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ABSTRACT 
Three new alkamides, zanthoamides G-I (1-3), together with ten known compounds, 
araliopsine, skimmianine, N-methylplatydesminium cation, isoplatydesmine, myrtopsine, 
atanine, N-methylatanine, sesamin, hesperetin and hesperidin, were isolated from the fruits of 
Zanthoxylum zanthoxyloides. Their structures were elucidated by spectroscopic means. All 
isolated compounds were assessed for their cytotoxicity against A549, MCF7, PC3 and PNT2 
cell lines. Among the alkamides, only zanthoamide G (1) showed low level of cytotoxicity 
against MCF7 cells. 
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1. Introduction 
The genus Zanthoxylum L. (family- Rutaceae) consists of ca. 250 species of trees and 
shrubs, distributed throughout tropical and temperate regions of the world (Global Biodiversity 
Information Facility, 2017). In Africa, this genus is represented by 35 species, many of which 
are used as spices, edible fruits, medicinal plants and wood for construction (Chase et al., 1999; 
Seidemann et al., 2005; Matu, 2011). Zanthoxylum zanthoxyloides (Lam.) Zepern. & Timler 
(synonyms - Fagara zanthoxyloides Lam. and Zanthoxylum senegalense DC), one of the 
African Zanthoxylum species, is a small tree (6-8 m), which is widely cited in African 
traditional medicine. Different parts of the plant are traditionally used in the forms of infusion 
and decoction to treat diseases such as malaria, fever, sickle cell anemia, tuberculosis, 
paralysis, elephantiasis, toothache, venereal diseases, dysmenorrhea, abdominal pain, cough, 
tuberculosis, urinary disorders, cancers and arthritis (Odebeyi and Sofowora, 1979; Amvam et 
al., 1998). In Cameroon, a decoction from Z. zanthoxyloides fruits is used for the treatment of 
cancers, sickle cell anemia and as a spice to cook special potages used as a purgative 
(Adjanohounet al., 1986; Tchiegang and Mbougueng, 2005). Previous phytochemical studies 
on the fruits revealed the presence of quinic acid derivatives and acridone alkaloids with 
aromatase properties (Ouattara et al., 2009; Wouatsa et al., 2013). Antifungal and antioxidant 
isobutylamides and cytotoxic benzophenanthridine alkaloids were reported from the roots 
(Sofowora et al., 1975; Chaaib et al., 2003; Adesina, 2005; Queiros et al., 2006). Other 
previously isolated compounds from the plant include aporphine and quinoline alkaloids, 
coumarins, lignans and various phenolic compounds (Adesina, 2005). In this paper, in 
continuation of our studies on Cameroonian medicinal plants (Wansi et al., 2016; Guetchueng 
et al., 2017, 2018; Tahsin et al., 2017), we now report on the isolation and identification of 
three new alkamides, zanthoamides G-I (1-3), together with ten known compounds (4-13) from 
the fruits of Z. zanthoxyloides, collected from Cameroon, and assessment of their cytotoxicity 
against three human cancer cell lines, adenocarcinomic alveolar basal epithelial (A549), breast 
adenocarcinoma (MCF7) and prostate cancer (PC3) and the normal human prostate epithelium 
(PNT2) cell lines.  
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2. Results and discussion 
Reversed-phase preparative HPLC purification  of the methanolic extract of the fruits 
of Z. zanthoxyloides afforded three new alkamides, named zanthoamides G-I (1-3), along with 
ten known compounds including: eight quinoline alkaloids, araliopsine (4), skimmianine (5), 
N-methylplatydesminium cation (6), isoplatydesmine (7), myrtopsine (8), atanine (9) and N-
methylatanine (10), a lignan, sesamin (11) and two flavanones, hesperetin (12) and hesperidin 
(13)  (Fig. 1). Whilst the new compounds were identified by extensive 1D and 2D NMR and 
HRMS analyses, the known compounds were identified by comparison of their spectroscopic 
data with respective literature data (Brown  et al., 1980; Ngadjui et al., 1988; Liu  et al., 2000; 
El-Shafae, 2002; Albarici et al., 2010; Haque et al., 2013).  
Compounds 1-3 were obtained as white viscous liquids. The molecular formula of 
compound 1 was determined as C18H29NO4 by HRESIMS from the pseudomolecular ion at m/z 
346.1984, calculated 346.1989 for its sodium adduct [M + Na]+ (C18H29NO4Na). The 
1H NMR 
spectrum of 1 (Table 1) exhibited 14 signals corresponding to 24 protons including the signals 
of the proton of a secondary amine at 8.56 (1H, br s), six olefinic protons at δ7.12 (1H, dd, J = 
10.4, 15.1), 6.60 (1H, dd, J = 11.1, 15.1), 6.27 (1H, dd, J = 10.8, 15.1), δ5.99 (1H, d, J = 15.0), 
5.70 (1H, dd, J = 6.4, 15.0) and 5.44 (1H, m, J = 7.4), signals at δ1.18 (6H, s) and 1.11 (3H, d, 
J = 6.3) for three methyls, two oxygenated methines at δ3.58 (1H, m, J = 6.3) and 3.91 (1H, 
dd, J = 6.4, 12.9) and three methylene signals including a broad singlet at δ3.27 and two double 
doublets at δ2.29 (J = 7.0, 13.2) and 2.35 (J = 7.3, 14.8). Overlapping signals occurring between 
δ6.0-6.15 ppm resulting from two olefinic protons resonances were also observed. The 13C 
NMR spectrum (Table 1) revealed signals for 18 carbons attributable to three methyls (δ27.2 
x 2, δ18.8), three methylenes with one appearing relatively downfield at δ51.1, ten methines 
including two oxymethines at δ77.8 and 71.7, eight olefinic methines at δ143.0, 142.3, 134.0, 
131.7, 130.2, 129.9, 128.2 and 123.2, and two quaternary carbons including an amide at δ169.4 
and an oxygenated quaternary carbon at δ71.6. The assignment of the carbon signals was 
consistent with the resonances observed in the 1H NMR experiment as well as the 1J 1H-13C 
correlations observed in the HSQC-DEPTQ spectrum. In the 1H-1H COSY spectrum, a chain 
of vicinal correlations observed from H-2 to H-14 (Fig. 2), which helped to construct one part 
of the compound structure as CH3-CH=CH-CH=CH-CH2-CH2-CH=CH-CH=CH-. In the 
HMBC spectrum, correlations from δ1.18 (H-3’ and H-4’) to carbon signals at δ51.1 (C-1’), 
71.6 (C-2’) and 27.2 (C3’ or C-4’), and from δ 3.27 (s, H-1’) to C-2’, C-3’ and C-4’ identified 
the other part of the molecule as 2-hydroxy-isobutyl moiety. Further correlations in the HMBC 
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spectrum from H-1’ (3.27), H-2 (δ5.99) and H-3 (δ7.12) to C-1 (δ169.4), in addition to the 
appearance of the methylene of the isobutyl moiety at δ55.1, established that the 2-hydroxy-
isobutyl moiety was linked to the nitrogen of the amide group and the aliphatic moiety to the 
carbonyl of the amide. The geometry of the double bond C2/C3 was deduced as trans (JH2/H3= 
15.0 Hz) like those of C4/C5, C8/C9 and C10/C11. Compound 1 did not show any optical 
activity suggesting that it was obtained as a racemic mixture. Thus compound 1 was identified 
as (12RS, 13RS)-(2E, 4E, 8E, 10E)-N-(2-hydroxy-2-methylpropyl)-12,13-dihydroxy-2,4,8,10-
tetradecatetraenamide, given the trivial name zanthoamide G (1). The structure of zanthoamide 
E (1) resembled that of zanthoamide C isolated from Zanthoxylum bungeanum (Wang et al., 
2016) with the only difference being the additional olefinic bond between C3 and C6 present 
in 1. Furthermore, the structure of 1 was supported by the fragmentation pattern observed in 
the EIMS experiment. The peaks corresponding to [M-C2H5O]
+ and [M-H2O-C2H5O]
+ could 
be attributed to the loss of the hydroxylated fragments on the aliphatic side on the molecule 
while peaks matching [M-CH3]
+, [M-H2O]
+ and [M-C2H6]
+ could be characteristic for the loss 
of fragments on the 2-hydroxy-isobutyl moiety. 
The molecular formula of compound 2 was determined as C18H29NO4 from its 
HRESIMS spectrum, where a pseudomolecular ion was observed as at m/z 346.1992 [M + Na]+ 
(calculated 346.1989 for C18H29NO4Na). The 
1H and 13C NMR spectra (Table 1) of 2 
established it as an aliphatic amide, similar to 1, with the only difference being the placement 
of the oxymethines, which were not adjacent to each other like in 1. A 1H-1H COSY spectrum 
revealed scaler couplings between oxymethine at δ4.28 (H-13) and methyl at δ1.20 (H-14) and 
also with the olefinic proton at δ5.73 (H-12), and the correlation from the other oxymethine at 
δ4.10 (H-8) to the methylene at δ1.60 (H-7) and the olefinic proton at δ5.68 (H-9) (Fig. 2). 
These correlations could be further confirmed from the HMBC spectrum, where correlations 
from H-8 to C-6 (δ29.9), C-7 (δ37.4) and C-9 (δ137.0), and from H-13 to C-12 (δ138.6) and 
C-14 (δ23.5) were observed (Fig. 2). The geometry of the olefinic bonds were confirmed as 
trans from relevant coupling constants (JH2/H3= 15.1, JH4/H5= 15.2, JH9/H10= 14.6 and JH11/H12= 
14.5). Compound 2 was optically inactive suggesting that it was a racemic mixture. Thus, 
compound 2 was identified as (8RS, 13RS)-(2E, 4E, 9E, 11E)-N-(2-hydroxy-2-methylpropyl)-
8,13-dihydroxy-2,4,9,11-tetradecatetraenamide, and given the trivial name, zanthoamide H (2). 
The structure of zanthomide H (2) is quite similar to that of zanthoamide B isolated from Z. 
bungeanum (Wang et al., 2016) with the only difference being the hydroxyl groups are in 
positions 8 and 13 in 2, whilst in zanthoamide B, they are in positions 6 and 13. It should be 
6 
 
noted that in the published paper (Wang et al., 2016) the IUPAC name given to zanthoamide 
B was erroneous and should be reviewed to (6RS, 13RS)-(2E, 4E, 9E, 11E)-N-(2-hydroxy-2-
methylpropyl)-6,13-dihydroxy-2,4,9,11-tetradecatetraenamide to comply with the 
corresponding discussion and published spectroscopic data supporting the two –OH groups in 
that molecule to be in positions 6 and 13.  
Compound 3 has a molecular formula of C18H27NO4, determined from the 
pseudomolecular ion [M + H]+ observed at m/z 322.2017 in its HRESIMS (calculated 322.2013 
for C18H28NO4). 
1H and 13C NMR data (Table 1) of 3 indicated that like 1 and 2, it was also an 
aliphatic amide, and there were spectral similarities with compound 2, with the obvious 
difference being the absence of the C-8 hydroxyl group as observed in 2, and the presence of a 
ketone group in 3 instead, which was confirmed by the signal at δ202.0 in the 13C NMR 
spectrum (Table 1). The position of the ketone group was confirmed from the HMBC 
experiment, where correlations were observed between the ketone carbonyl carbon (δ202.0) 
and the protons at δ2.48 (H-6), 6.21 (H-9), 2.79 (H-7) and 7.29 (H-10) (Fig. 2). This was also 
supported by the downfield shifts of C-10 and C-12 from δ129.8 and 138.6 in 2 to δ144.5 and 
149.3, respectively, in 3, caused by the presence of a ketone group nearby. The geometry of 
the double bonds C2/C3, C4/C5, C9/C10 and C11/C12 was determined as trans from the 
relevant coupling constants, J = 15.0, 15.0, 15.6 and 15.1, respectively. Unlike compounds 1 
and 2, compound 3 was found to be optically active, [α]D25 = -25.6. However, the absolute 
configuration could not be determined because of paucity of this sample. Thus, compound 3 
was identified as (13*)-(2E, 4E, 9E, 11E)-N-(2-hydroxy-2-methylpropyl)-13-hydroxy-
2,4,9,11-tetradecatetraenamide and given the trivial name, zanthoamide I (3). 
This is the first report on the occurrence of compounds 4, 6-8 and 10, in addition to 
three new alkamides (1-3), in Z. zanthoxyloides. Several alkamides with structures similar to 
zanthoamides G-I (1-3) were previously reported in several Zanthoxylum species including  Z. 
achtoum, Z. ailanthoides, Z. armatum, Z. bungeanum, Z. heitzii, Z. integrifoliolum, Z. 
piperitum, Z. schinifolium, Z. syncarpum, Z. tessmannii  and Z. zanthoxyloides (Ross et al., 
2005; Wang et al., 2016; Chruma et al., 2018). Araliopsine (4) was previously isolated from Z. 
simulans (Chang et al., 1981), N-methylplatydesminium catium (6) from Z. usambarense and 
Z. chalybeum (Kato et al., 1996), isoplatydesmine (7) from Z. nididum (Ishikawa et al., 1995), 
myrtopsine (8) from Z. integrifoliolum (Ishii et al., 1982) and N-methylatanine (10) from Z. 
beecheyanum (Cheng et al., 2004) and Z. rigidum (Moccelini et al., 2009).    
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Compounds 1-13 were evaluated for their cytotoxicity against A549 (adenocarcinomic 
human alveolar basal epithelial), MCF7 (human breast adenocarcinoma), PC3 (human prostate 
cancer) and PNT2 (human normal prostate epithelium) cells (Table 2). Among the tested 
compounds, hesperidin (13) showed a moderate level of cytotoxicity against A549, MCF7 and 
PC3 cells with IC
50
 values of 29.5±7.5, 74.2±17.8 and 51.7±8.7 μM, respectively, with the IC50 
value for the normal cell line (PNT2) being 129.0±20.3 μM. Skimmianine (5) and sesamin (11) 
were moderately active against MCF7 and PC3 cells, exhibiting IC
50
 values of 53.7±09.5 and 
33.4±9.8 μM, respectively. None of the isolated new compounds (1-3) was particularly 
cytotoxic against the cell lines at the test concentrations (0-200 μM). However, only 
zanthoamide G (1) showed some cytotoxicity against MCF7 cells (IC50 = 153.6±32.7M). 
Several alkamides isolated from the Zanthoxylum genus have been found to possess weak or 
moderate cytotoxicity (Devkota et al., 2012; Wang et al., 2017).  Additionally, alkamides 
possess antidiabetic, anti-inflammatory, immunomodulatory and nerve growth factor 
potentiating properties (Greger, 2016; Tian et al., 2016; Wang et al., 2017). 
 
 
3. Materials and methods 
3.1. General experimental procedures  
Analytical and preparative TLC were carried out on 0.2 mm Sigel 60 F254 plates (Merck, 
Germany). Spots were visualized under short (254 nm) and long wavelength (366 nm), and 
also by spraying with a 1% anisaldehyde solution in aqueous H2SO4 followed by heating to 
105°C for 5 min. The NMR spectroscopic analyses were performed in CD3OD or CDCl3 
solution on a Bruker AMX300 instrument (300 MHz for 1H and 75 MHz for 13C) or Bruker 
AMX600 NMR spectrometer (600 MHz for 1H and 150 MHz for 13C). HRESIMS analyses 
were performed on a Xevo G2-S ASAP or LTQ Orbitrap XL1 spectrophotometer. EIMS 
analysis was recorded on a Finnigan MAT 95 spectrometer. Analytical HPLC was performed 
on a Dionex UPLC 3000 (Thermoscientific, UK) HPLC coupled with a photo-diode-array 
(PDA) detector (Thermoscientific). Extracts and fractions were analyzed on a Phenomenex C18 
column (150 × 4.6 mm, 5 m, Phenomenex, USA). An Agilent 1200 Infinity series preparative 
HPLC system coupled with a PDA detector (Agilent, UK) was used to isolate compounds; a 
Hichrom ACE C18 preparative column (150 × 21.2 mm, 5 m) was used . The column 
temperature was set at 25 °C. The chromatogram was monitor at variable UV–vis wavelengths 
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(215, 254, 280 and 320 nm). Optical rotation was determined using Bellingham-Stanley 
ADP660 polarimeter (MeOH, c in g/100mL). UV spectra were recorded on Analytik Jena 
Specord 210 spectrophotometer. IR was recorded on an Agilent Cary 630 FT-IR.  
 
3.2. Plant material 
The fruits of Z. zanthoxyloides were collected from Dschang local market, Western 
Region, Cameroon, in November 2015, and identified by Mr Victor Nana, a taxonomist at the 
Cameroon National Herbarium, by comparing the plant sample with the voucher specimen 
21793/SFR/CAM. 
3.3. Extraction and isolation of compounds 
The air-dried ground fruits (350.0 g) of Z. zanthoxyloides were Soxhlet-extracted, 
successively, with n-hexane, DCM and MeOH (800 mL, 10 cycles each). After evaporation at 
40oC under reduced pressure, 34.6 g, 3.9 g and 19.6 g of n-hexane, DCM and MeOH extracts 
were obtained, respectively. A portion of the dried MeOH extract (2 g) was suspended in 10 mL 
of 10% MeOH- water and loaded on to a Strata C-18-E cartridge (Phenomenex, USA) (20 g), 
previously washed with MeOH (50 mL), followed by equilibration with water (100 mL). The 
cartridge was eluted with MeOH–water mixture of decreasing polarity to obtain four fractions: 
20, 50, 80 and 100% MeOH in water (200 mL each) (F1-F4, respectively). All fractions were 
concentrated to dryness using a combination of rotary evaporator and freeze-dryer and stored 
at 4oC until further use. F3 (845.8 mg) was subjected to preparative HPLC using an ACE prep-
column (150 × 21.2 mm, Hichrom Ltd, UK), flow rate 10 mL/min, mobile phase gradient of 
water (A) and methanol (B) both containing 0.1% TFA: 30-100% B, 0-30 min; 100% B, 30-35 
min; 100-30% B, 35-40 min, monitored at wavelengths 254 and 280 nm to yield N-
methylplatydesmine cation (12.1 mg) (6), myrtopsine (2.3 mg) (8), hesperidin (1.8 mg) (12), 
hesperetin (2.4 mg) (12), skimmianine (7.8 mg) (5), atanine (3.3 mg) (9), N-methylatanine (2.8 
mg) (10) and sesamin (4.5 mg) (11) having the retention times (tR) 3.2, 7.5, 19.2, 24.8, 25.7, 
29.3, 30.8 and 31.9  min, respectively.  
F2 (704.8 mg) was also analyzed by preparative HPLC as above, but with a different 
mobile phase: a gradient of water containing 0.1% TFA (A) and acetonitrile (B): 30-100% B 
over 30 min and monitor at wavelengths 254 and 280 nm to yield N-methylplatydesmine cation 
(3.5 mg) (6) and isoplatydesmine (3.6 mg) (7) having the retention times (tR) 3.1 and 5.3 min, 
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respectively. Fraction F2-B (5.7 mg) collected at tR = 4.8 min was further purified through 
preparative TLC to afford 2 (3.2 mg, EtOAc-MeOH 70:30, Rf 0.41). Fraction F2-D (3.6 mg) 
collected at tR = 5.5 min was also purified by preparative TLC to obtain 3 (1.9 mg, EtOAc-
MeOH 70:30, Rf 0.46). Preparative TLC of fraction F2-E (3.8 mg) collected at tR =  6.2 min 
provided 1 (1.8 mg, EtOAc-MeOH 70:35, Rf 0.41). Purification of fraction F2-F (10.2 mg) 
collected at tR = 6.5 min using TLC with a mixture of EtOAc-MeOH (70:35) as eluent afforded 
more of 1 (2.5 mg, Rf 0.41) and ariolipsine 4 (3.6 mg, Rf 0.28). 
 
3.4. Zanthoamide G (1)  
White viscous liquid; [α]D25 +0.0 (c 0.004, MeOH); UV λmax (nm): 236, 260; FT-IR 
(ATR) νmax (cm-1): 3380, 2920, 2850, 1580; HRESIMS m/z 346.1984 [M + Na]+ (calc 346,1989 
for C18H29NO4Na,); EIMS m/z (rel. int.): 278 (100) [M-C2H5O]
+, 260 (95) [M-H2O-C2H5O]
+, 
293 (5) [M-2xCH3]
+, 305 (5) [M-H2O]
+, 308 (2) [M-CH3]
+; see Table 1 for 1H NMR (600 MHz, 
CD3OD) and 
13C NMR (150 MHz, CD3OD) data. 
3.5. Zanthoamide H (2) 
White viscous liquid; [α]D25 +0.0 (c 0.006, MeOH); UV λmax (nm): 232, 262; FT-IR 
(ATR) νmax (cm-1): 3325, 2950, 2920, 2840, 1680, 1600, 1535; HRESIMS m/z 346.1992 [M + 
Na]+ (calc 346,1989 for C18H29NO4Na); EIMS m/z (rel. int.): 323 (10) [M]
+, 306 (11) [M+H-
H2O]
+, 263 (27) [M-C3H6O]
+, 183 (45) [M+H-C8H13O2]
+, 165 (65) [M+H-H2O-C8H13O2]
+; see 
Table 1 for 1H NMR (600 MHz, CD3OD) and 
13C NMR (150 MHz, CD3OD) data. 
3.6. Zanthoamide I (3)  
White viscous liquid; [α]D25 – 25.6 (c 0.013, MeOH); UV λmax (nm): 214, 264; FT-IR 
(ATR) νmax (cm-1): 3380, 2920, 2860, 2920, 2850, 1680, 1620, 1550, 980; HRESIMS m/z 
322.2017 [M+H]+ (calc 322.2013 for C18H28NO4); EIMS m/z (rel. int.): 321 (15) [M]
+, 303 
(17) [M-H2O]
+, 273 (20) [M-C2H5O]
+, 263 (90) [M- C3H6 O]
+; see Table 1 for 1H NMR (600 
MHz, CD3OD) and 
13C NMR (150 MHz, CD3OD) data. 
3.7. Cytotoxicity assay 
The in vitro antiproliferative (cytotoxic) activity of all the isolated compounds (1-13) 
from Z. zanthoxyloides was assessed against A549, MCF7 and PC3 human cancer cell lines, 
and also against normal prostate epithelium cells (PNT2). The cell lines were grown in RPMI 
medium supplemented with L-glutamine (2 mM), penicillin (100 U/mL), streptomycin (100 
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μg/mL) and 10% fetal bovine serum (FBS). The cells were cultured at 37°C, 5% CO2 and 95% 
humidity and were seeded into 96 wells plate (1.2×104/well) and incubated for 24h. The cells 
were then treated for 48h with the isolated compounds (0 to 200 µM) before the cell viability 
was assessed using the MTT assay (Mosmann, 1983). To achieve this, the medium in each well 
was replaced by MTT solution (500 μg/mL in medium) and incubated for 2h. The toxicity of 
the compounds was assessed by the ability of the cells to reduce the yellow MTT dye to blue 
formazan crystals. The formazan crystals formed were dissolved in DMSO and optical density 
was read at 570 nm in a ClarioStar plate reader. Three individual wells were assayed per 
treatment; the assay was repeated three times and cytotoxic activity was determined as 
percentage of control cells [(absorbance of treated cells/absorbance of untreated cells) × 100]. 
Doxorubicin was used as positive control and the IC50 value of each test sample was calculated 
using the software Graphad Prism 7.02. 
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Fig. 1. Structures of zanthoamides G-I (1–3) 
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Fig. 2. 1H-1H COSY and some key HMBC correlations of zanthoamide G-I (1-3) 
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Table 1.  
1H (600 MHz) and 13C (150 MHz) NMR data of zanthoamides G-I (1-3)a 
Position Chemical shift  in ppm 
1H (J in Hz) 13C 
1 2 3 1 2 3 
1 - - - 169.4 169.5 169.4 
2 5.99 d (15.0) 6.01 d (15.1) 6.01 d (15.0) 123.2 123.1 123.5 
3 7.12 dd (10.4, 15.1) 7.15 dd (10.7, 15.0) 7.13 dd (10.7, 15.1) 142.3 142.4 142.1 
4 6.27 dd (10.8, 15.1) 6.25 dd (10.7, 15.2) 6.26 m 130.2 130.1 130.4 
5 6.11 m 6.14 m 6.13 dt (7.0, 15.0) 143.0 143.4 142.2 
6 2.29 dd (7.0, 13.2) 2.20 m 2.48 dd (7.2, 14.1) 33.9 29.9 28.4 
7 2.35 dd (7.3, 14.8) 1.60 m 2.79 dd (7.2, 14.5) 28.0 37.4 39.9 
8 5.44 dd (7.2, 15.1) 4.10 q (6.5, 13.0) - 131.7 72.4 202.0 
9 6.07 m 5.68 dd (6.7, 14.6) 6.21 d (15.6) 129.9 137.0 130.2 
10 6.60 dd (11.1, 15.1) 6.20 m 7.29 dd (10.8, 15.6) 128.2 129.8 144.5 
11 5.70 dd (6.4, 15.0) 6.20 m 6.42 dd (10.3, 15.1) 134.0 131.0 128.0 
12 3.91 dd (6.4, 12.9) 5.73 m 6.31 m 77.8 138.6 149.3 
13 3.58 m 4.28 q (6.3, 12.5) 4.38 m 71.7 68.8 68.4 
14 1.11 d (6.3) 1.20 d (6.4) 1.22 d (6.5) 18.8 23.5 23.1 
1’ 3.27 s 3.28 s 3.27 s 51.1 51.1 51.1 
2’ - - - 71.6 71.6 71.5 
3’ 1.18 s 1.19 s 1.18 s 27.2 27.2 27.2 
4’ 1.18 s 1.19 s 1.18 s 27.2 27.2 27.2 
NH 8.56 br s 8.56 br s 8.56 br s - - - 
aSpectra obtained in CD3OD, and DEPTQ, COSY, HSQC and HMBC experiments confirmed 
assignment of all 1H and 13C signals 
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Table 2 
Cell Growth Inhibitory Activities (IC50 in µM) of Isolated Compounds against Cancer (A549, MCF7, 
PC3) and Normal (PNT2) Cells* 
Compounds IC50 values in M 
A549 MCF7 PC3 PNT2 
1 >200 153.6±32.7 >200 >200 
2 >200 >200 >200 181.6±35.7 
3 >200 >200 >200 >200 
4 >200 >200 >200 >200 
5 113.4±15.8 53.7±09.5 164.7±21.3 104.4±16.2 
6 >200 152.2±33.6 >200 >200 
7 >200 172.2±31.4 >200 >200 
8 >200 >200 >200 >200 
9 112.0±17.4 >200 195.3±22.6 >200 
10 114.7±18.2 142.5±17.0 >200 >200 
11 108.5±22.1 >200 33.4±9.8 >200 
12 151.4±25.4 >200 159.7±28.5 >200 
13 29.5±7.5 74.2±17.8 51.7±8.7 129.0±20.3 
Doxorubicin 1.3±0.3 0.7±0.1  16.4±2.9  1.5±0.3  
*Data are represented as mean ± SEM (n = 3); IC50 = sample concentration that caused 50% 
cell growth inhibition  
 
 
 
 
 
 
